SYF

Synchrony Financial Reports $102.3 Billion in Loan Receivables

Synchrony Financial has released its monthly charge-off and delinquency statistics for the thirteen months ended June 30, 2024. The period-end loan receivables as of June 30, 2024, amounted to $102.3 billion, showing a slight decrease from the previous month's $102.4 billion.

The 30+ delinquency rate as of June 30, 2024, stood at 4.5%, consistent with the rate in May 2024, but showing an increase from 3.8% in June 2023. The net charge-off rate for June 2024 was 6.1%, slightly down from 6.5% in May 2024, and up from 4.7% in June 2023.

The average loan receivables, including those held for sale, were $102.0 billion for June 2024, up from $101.4 billion in May 2024, and reflecting a gradual increase from $93.9 billion in June 2023.

The recovery adjustment for June 2024 was 0.1%, compared to (0.1)% in May 2024 and 0.1% in June 2023. When considering the adjusted net charge-off rate, which includes the recovery adjustment, June 2024 saw a rate of 6.1%, marking a slight decrease from 6.4% in May 2024, and an increase from 4.7% in June 2023.

These metrics demonstrate the continued impact of moderation in customer payment rates, with both the 30+ delinquency rate and net charge-off rate showing year-over-year increases, reflecting a notable change in the company's financial performance compared to the same period in the previous year. The market has reacted to these announcements by moving the company's shares 2.0% to a price of $51.71. For more information, read the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS